Eikon Therapeutics

HAYWARD, CA · Founded 2019 · Biotech · Public

Cryo-electron microscopy (cryo-EM) platform for high-resolution structure determination of drug targets

Claim this profile

Follows are private to you and power your alerts

Updated · eikontx.com

Sector
Biotech
Headquarters
HAYWARD, CA
Founded
2019
Latest Form D
$351M, Feb 2025
Total capital
$1.1B
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.1B
4 Form D · last Feb 2025
20 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
39 pending · first 2026
Rank in peer group#7 of 22

Capital timeline

20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $1.1B1st Form D$103M2nd Form D$518M3rd Form D$141M4th Form D$351M
20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $1.1B2nd Form D$518M4th Form D$351M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$351M
  • Private capital raisedForm D · SEC · 3rd filing$141M
  • Private capital raisedForm D · SEC · 2nd filing$518M
  • Private capital raisedForm D · SEC · 1st filing$103M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 22 peers

Line = median

Biotech · Instrument

  • Granted patents#7 · top 32%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Adam M. GoulburnDirectorNamed in SEC Form D filings
  • Alfred M. BowieExecutive OfficerNamed in SEC Form D filings
  • Ashish M. KheterpalExecutive OfficerNamed in SEC Form D filings
  • Barbara M. HowesExecutive OfficerNamed in SEC Form D filings
  • Benjamin M. ThornerExecutive OfficerNamed in SEC Form D filings
  • Dan M. AndersonExecutive OfficerNamed in SEC Form D filings
Show all 17 people
  • Dror M. BermanDirectorNamed in SEC Form D filings
  • James M. TananbaumDirectorNamed in SEC Form D filings
  • Joshua M. WolfeDirectorNamed in SEC Form D filings
  • Josh M. WolfeDirectorNamed in SEC Form D filings
  • Kenneth M. FrazierDirectorNamed in SEC Form D filings
  • Leon M. ChenDirectorNamed in SEC Form D filings
  • Robbie M. HuffinesDirectorNamed in SEC Form D filings
  • Robin M. WashingtonDirectorNamed in SEC Form D filings
  • Roger M. PerlmutterExecutive Officer, DirectorNamed in SEC Form D filings
  • Roy M. BanesExecutive OfficerNamed in SEC Form D filings
  • Russ M. BermanExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 40
  • PendingPhotoactive Fluorescent Compounds And Use Thereof For Labeling Of ProteinsUSPTOApplication 19546172
  • PendingMethods And Compositions For Assessing The Performance Of Instruments Adapted For Single-molecule TrackingUSPTOApplication 19564475
  • GrantedPhotoactive Fluorescent Compounds And Use Thereof For Labeling Of ProteinsUSPTOUS 12,681,018
Show all 40 patent records
  • Photoactive Fluorescent Compounds And Use Thereof For Labeling Of ProteinsSep 3, 2026 · Application 19546172Pending
  • Methods And Compositions For Assessing The Performance Of Instruments Adapted For Single-molecule TrackingJul 23, 2026 · Application 19564475Pending
  • Photoactive Fluorescent Compounds And Use Thereof For Labeling Of ProteinsJul 14, 2026 · US 12,681,018Granted
  • End-effectors For Sample-handling Robotic SystemsJun 25, 2026 · Application 19541875Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsJun 18, 2026 · Application 19244379Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsJun 11, 2026 · Application 19244695Pending
  • Methods And Systems For Single Molecule Tracking In Cell-free SystemsApr 30, 2026 · Application 19431552Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsOct 9, 2025 · Application 19244317Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsOct 9, 2025 · Application 19244635Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsOct 9, 2025 · Application 19244543Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsOct 9, 2025 · Application 19245048Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsOct 9, 2025 · Application 19244938Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsOct 9, 2025 · Application 19245025Pending
  • Methods And Compositions For Assessing The Performance Of Instruments Adapted For Single-molecule TrackingApplication PCTUS2024046375Pending
  • Compositions Comprising Werner Syndrome Helicase Inhibitors And Methods Of Using The SameApplication PCTUS2024044435Pending
  • End-effectors For Sample-handling Robotic SystemsApplication PCTUS2024042701Pending
  • Compositions Comprising Werner Syndrome Helicase Inhibitors And Methods Of Using The SameApplication 63665217Pending
  • Methods Of Treating CancerApplication 63653632Pending
  • Cell Healthiness Characterization Using Machine LearningApplication PCTUS2024014937Pending
  • Nucleolar Localization Using Machine- Learning-based Inference And SegmentationApplication PCTUS2024014922Pending
  • Systems And Methods For Image Processing And Adaptive Control In Microscope SystemsApplication 63549226Pending
  • Photoactive Fluorescent Compounds And Use Thereof For Labeling Of ProteinsApplication PCTUS2024013113Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085581Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085571Pending
  • Methods And Systems For Single Molecule Tracking In Cell-free SystemsApplication 63613704Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085594Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085589Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085593Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085563Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085587Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085409Pending
  • Oblique Line Scanner Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085592Pending
  • Systems And Methods For High Throughput Single Molecule Tracking In Living CellsApplication PCTUS2023085590Pending
  • Compositions Comprising USP1 Inhibitors And Methods Of Using The SameApplication 63610860Pending
  • Compositions Comprising USP1 Inhibitors And Methods Of Using The SameApplication 63610849Pending
  • Synthesis of Substituted Tricyclic CompoundsApplication 63609795Pending
  • Single Molecule Tracking Using Graph Neural NetworksApplication 63584458Pending
  • Methods And Compositions For Assessing The Performance Of Instruments Adapted For Single-molecule TrackingApplication 63538056Pending
  • Compositions Comprising Werner Syndrome Helicase Inhibitors And Methods Of Using The SameApplication 63535307Pending
  • End-effectors For Sample-handling Robotic SystemsApplication 63520573Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .